Clinical Trials Logo
  1. Home
  2. Rheumatic Diseases
  3. NCT02926560

Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism

Rheumatic Diseases Clinical Trial

NCT number NCT02926560
Study type Observational
Source Centre Hospitalier Universitaire de Nimes
Contact Cécile Gaujoux-Viala, MD,PhD
Email cecile.gaujoux.viala@chu-nimes.fr
Status Recruiting
Phase N/A
Start date June 1, 2016
Completion date March 2018
View Details

Clinical Trial Summary

The aim of this study is

1) To describe the level and determinants of methotrexate adherence in patients with chronic inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) in the department of rheumatology in the Nîmes University Hospital

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
See also
  Status Clinical Trial Phase
Completed NCT02944448 - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee Phase 2
Recruiting NCT02694796 - Impact of Web and Smartphone-based Physical Activity Program on Physical Activity Level 12 Months After a Balneotherapy N/A
Enrolling by invitation NCT02269254 - Persona Versus NexGen N/A
Completed NCT02256098 - RSA RCT: ATTUNE™ TKA Versus PFC Sigma TKA N/A
Completed NCT00642837 - A Study on Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg Tablets Phase 4
Completed NCT02291471 - Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers Phase 1
Completed NCT01227694 - Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis Phase 1/Phase 2
Recruiting NCT01071447 - Nurse-led Clinic for Patients With Rheumatic Diseases and Biological Treatment N/A
Recruiting NCT02694185 - Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications N/A
Not yet recruiting NCT01006681 - Vaccination Against Influenza H1N1 in Rheumatic Diseases Phase 2
Active, not recruiting NCT03371303 - Analysis of Changes in Medication Prescriptions After Hospitalization for 4 Disciplines: Gerontology, Diabetology, Cardiology and Rheumatology: Medical, Pharmaceutical and Economic Aspects N/A
Not yet recruiting NCT03492658 - Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA) Phase 4
Completed NCT02430402 - Rehabilitation of Young Patients With Rheumatic Diseases in a Warm Climate N/A
Enrolling by invitation NCT02717559 - Multicenter Orthopaedic Outcomes Network (MOON) ACL Reconstruction (ACLR): 10 Year Onsite Follow-up N/A
Completed NCT01656278 - An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis N/A
Completed NCT00665275 - Complementary and Alternative Medicine Among Outpatients With Inflammatory Rheumatic Diseases in Western Sweden N/A
Recruiting NCT03293719 - Post-market Follow up Study of the 'BPK-S Integration' UC as Primary Implant in the Variants CoCr or Ceramic
Enrolling by invitation NCT02508428 - Marathon and Enduron Polyethylene at Long-Term Follow-up N/A
Recruiting NCT02111564 - A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients Phase 3
Terminated NCT02829814 - Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia Phase 3